The QualityStocks Daily Stock List
- AgraFlora Organics International, Inc. (AGFAF)
- Cansortium, Inc. (CNTMF)
- International Spirits & Wellness Holdings, Inc. (ISWH)
- Jaguar Health, Inc. (JAGX)
- Sigma Lithium Resources Corporation (SGMLF)
- TearLab Corporation (TEAR)
- Valeritas Holdings, Inc. (VLRX)
- Cyber Security 1 AB (CYBNY)
- Metrospaces, Inc. (MSPC)
- Reeltime Rentals, Inc. (RLTR)
- Inspyr Therapeutics, Inc. (NSPX)
- Natcore Technology, Inc. (NTCXF)
- Atacama Resources International, Inc. (ACRL)
- Andrea Electronics Corp. (ANDR)
AgraFlora Organics International, Inc. (AGFAF)
TipRanks, Pot Stocks, IRW Newsletter, The WS News Publisher, Nasdaq, Marijuana Stocks, Pot Stock News, TradingView, Investing.com, Stockhouse, The Street, Dividend Investor, GlobeNewswire, Stockwatch, and Investors Hub reported earlier on AgraFlora Organics International, Inc. (AGFAF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
AgraFlora Organics International, Inc. is a growth oriented and diversified global cannabis company based in Vancouver, British Columbia. It owns an indoor cultivation operation (ACMPR licensed- 8,800 sq. ft.) in London, Ontario. The Company is also a joint venture partner (a 70 percent interest) in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, British Columbia. AgraFlora Organics International lists on the OTC Markets.
AgraFlora is a vertically integrated cannabis company equipped with a strong portfolio of licensed upstream, downstream and product formulation assets. In addition, the Company operates a flagship 51,500 sq. ft. edibles manufacturing facility in Winnipeg, Manitoba. AgraFlora’s brands include Canutra Naturals Ltd., Edibles and Infusions, HowlBrands, Whole Hemp Health, Eurasia Infused, True Focus, Potluck, and Health Cap Holdings.
AgraFlora has a world-class team with wide-ranging experience with natural farming techniques, biodynamics, genetics and strains. The basis of the Company’s products is on a very large library of proprietary genetics in clone and seed form that have been bred in premier conditions.
Last week, AgraFlora Organics International announced that its wholly-owned subsidiary Canutra Naturals was awarded a cannabis research licence by Health Canada under the Cannabis Regulations Act. The Research License permits Canutra Natural to pursue the development of proprietary cannabis genetics and phenotypes at its flagship 76-acre campus in Kent County, New Brunswick.
In combination with Canutra’s existing cannabis research and development partnership with the Universite de Moncton (UM) the Company will leverage its recently awarded Research License to augment its portfolio of inventive cannabis genetics and phenotypes. Canutra’s intention is to use its proprietary cannabis genetics and phenotypes as base-inputs for its set of premium cannabinoid-infused cosmetics that are currently marketed throughout North America, the People’s Republic of China, and the Hong Kong Special Administrative Region.
This week, AgraFlora Organics International provided an operational update and sales licensing guidance at its wholly-owned AAA Heidelberg craft cannabis cultivation facility in London, Ontario. The Company activated two flower rooms for the cultivation of ultra-premium craft cannabis flower; completed the installation of grow lights, grow tables, and fans for mother and veg rooms; and completed interior and exterior caulking and sealing of GPP walls and floors. The AAA Heidelberg facility is equipped with five partitioned flower rooms. This affords AgraFlora ample canopy earmarked for ultra-premium craft cannabis cultivation. The Company has a planned import of a portfolio of high-end cultivars under a declaration from Health Canada.
AgraFlora Organics International, Inc. (AGFAF), closed Thursday's trading session at $0.156, off by 7.3634%, on 1,372,222 volume with 164 trades. The average volume for the last 3 months is 521,897 and the stock's 52-week low/high is $0.090000003/$0.639699995.
Cansortium, Inc. (CNTMF)
New Cannabis Ventures, Stock Gumshoe, TipRanks, Market Screener, InvestorsHub, Proactive Investors, Nasdaq, Stock Target Advisor, Wallet Investor, TradingView, Stockwatch, Stockhouse, and Dividend Investor reported previously on Cansortium, Inc. (CNTMF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Cansortium, Inc. is a medical cannabis company with a worldwide mission to deliver the highest standards of cannabis care from nursery to laboratory to shelf. The Company is a vertically-integrated, worldwide provider of premium-quality medical cannabis operating under the Fluent™ brand (previously Knox Medical). Established in 2015, Cansortium is based in Miami, Florida. The Company lists on the OTC Markets Group’s OTCQB.
Cansortium operates in highly populous medical cannabis markets. The Company, via its subsidiaries, operates cultivation, processing and dispensary facilities across Florida, Texas, and Puerto Rico, and also a dispensary license in Pennsylvania. Additionally, Cansortium has licensed cultivation facilities in Colombia and Canada, with licensing pending in Michigan.
Extensive regulatory expertise enables the Company to navigate developing medical cannabis regulatory frameworks strategically positioned for fast growth in highly-regulated jurisdictions. As a vertically-integrated, and technologically-advanced business platform, Cansortium’s proprietary production methodologies are scalable and replicable.
Its state-of-the-art cultivation and processing technologies enable the production of a set of premium cannabis products. Cansortium’s Fluent brand is a vertically-integrated cultivator, processor, formulator, and retailer of premium cannabis products. Fluent has invested substantially in developing top-quality products and gaining more understanding of the potential of cannabis.
Cansortium continues to expand its Florida retail presence with the September 9th opening of a new Fluent dispensary in a prime location in Cape Coral, Florida. The new 3,440 square-foot dispensary is the Company's 15th in Florida. It is conveniently located in central Cape Coral at 103 SW 3rd Place. This new dispensary will serve the city's approximately 183,000 residents, and also customers in the northern section of nearby Fort Myers.
Cansortium's Chief Executive Officer, Mr. Jose Hidalgo said, "As one of the first five licensed operators in Florida - the State with the fastest-growing medical marijuana patient population in the U.S. – we continue to capitalize on our first-mover position, executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients across the State. We expect to open 6 more which will result in 21 Florida locations operating and generating revenue by the end of 2019. We currently have 18 locations secured for this continuing expansion.”
Cansortium, Inc. (CNTMF), closed Thursday's trading session at $0.634, off by 2.4615%, on 64,902 volume with 28 trades. The average volume for the last 3 months is 38,527 and the stock's 52-week low/high is $0.429800003/$2.50.
International Spirits & Wellness Holdings, Inc. (ISWH)
NewMediaWire, Undergroundstocks, Spotlight Growth, OTC Markets, Market Screener, Investor Ideas, Investor News, Financial Buzz, Stock News Feed, and Insider Tracking reported beforehand on International Spirits & Wellness Holdings, Inc. (ISWH), and today we report on the Company, here at the QualityStocks Daily Newsletter.
International Spirits & Wellness Holdings, Inc. (ISWH) is a top-tier brand incubator in the Global Wine & Spirits and CBD-Infused Products markets. It is an authorized importer, licensor, and marketer of premium beverage brands, with sales of unique products and brands internationally. The Company formerly went by the name International Spirits & Beverage Group, Inc. It changed its name to International Spirits & Wellness Holdings, Inc. this past July. ISWH lists on the OTC Markets.
ISWH develops and grows brands through all phases. This includes concept creation, product development, market positioning, and sales and marketing. Its goal is to be a global innovation leader within the alcohol beverage and cannabis industries. It will source early stage brands, existing brands with unrealized potential, and create in-house brands that raises innovation and expectations with trade and consumer. Additionally, ISWH has partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace.
ISWH’s latest brand is P19. This is the Company’s first entrance into the CBD (cannabidiol) space. It partnered with best-in-class CBD experts at BioPulse Labs. P19 was created around developing the finest CBD products such as gummies, topicals, tinctures, and more. Currently, ISWH’s Wine and Spirit portfolio is led by Besado Tequila. This is ISWH’s innovative entrance within the growing ultra-premium tequila segment. Furthermore, the Company’s Dziaq (dee-zee-ack) Liqueur re-brand to a wine based ready-to-serve cocktail line allows for considerably greater distribution channels (2 x spirit based alternatives).
Yesterday, ISWH issued a Corporate Update on its strategic roadmap for operations and revenue-generating activity in the final quarter of 2019. Sales of its P19 branded CBD-based product line are set to resume this month. ISWH believes that overall growth in the CBD space, and its strengthened position with its key strategic manufacturing, marketing, and distribution partner, BioPulse Labs, will create increased potential for outsized upside performance for the P19 segment in Q4 2019. ISWH will start actively marketing its nano-Infused CBD products, including P19 CBD Tinctures, P19 vegan CBD Gummies, P19 CBD Pain Cream, P19 Nano Nectar CBD Drops, and P19 Flavored CBD Shooters.
Regarding Home Healthcare, the Company has targeted major growth in the space over coming quarters, ramping investment as market returns continue to validate the thesis. So far, this strategy has been extremely productive, driving 6,400 percent sequential quarterly revenue growth in Q2 2019 (quarter-ended June 30).
Concerning Spirits, Spirits. ISWH Management notes that it has set in motion the process of a strong year-end production and distribution run for its award-winning Besado Tequila brand. October, November, and December, taken as a unit, represent greater than 40 percent in total annual sales for the spirits industry.
International Spirits & Wellness Holdings, Inc. (ISWH), closed Thursday's trading session at $0.0006, even for the day, on 15,843,052 volume with 19 trades. The average volume for the last 3 months is 41,332,881 and the stock's 52-week low/high is $0.0003/$0.039999999.
Jaguar Health, Inc. (JAGX)
Alpha Stock News, Stock Twits, Super Stock Screener, Market Screener, Stockwatch, Infront Analytics, Proactive Investors, TradingView, Street Insider, Stockhouse, and Investing.com reported previously on Jaguar Health, Inc. (JAGX), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Jaguar Health, Inc. is a commercial stage pharmaceutical company focused on developing novel, sustainably derived gastrointestinal products on a global basis. The Company’s wholly-owned subsidiary is Napo Pharmaceuticals, Inc. Napo concentrates on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the worldwide marketplace from plants used traditionally in rainforest areas. NasdaqGS-listed, Jaguar Health is based in San Francisco, California.
Jaguar’s mission is to identify human and animal health market opportunities where it can develop targeted products that leverage its broad intellectual property (IP) portfolio, deep pipeline, and wide-ranging botanical library. The Company’s emphasis is naturally derived health solutions for humans and animals.
Jaguar Health’s Mytesi® (crofelemer) product is approved by the U.S. FDA (Food and Drug Administration) for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. MYTESI® is not indicated for the treatment of infectious diarrhea.
Jaguar Health announced in August that Indena S.p.A., one of the two contract manufacturers of the active pharmaceutical ingredient (API) in crofelemer, successfully developed and implemented an improved crofelemer manufacturing process. This effectively increases yield and realizes reduced cost through increased manufacturing efficiencies. This is while keeping the same phytochemical profile without compromising product quality, safety, purity and efficacy.
The modified process enables Jaguar Health's wholly-owned human-health subsidiary, Napo Pharmaceuticals, to support the increased crofelemer manufacturing demand expected if crofelemer receives FDA approval for new indications. This includes approval for the symptomatic relief of cancer therapy-related diarrhea (CTD). Indena (Milan, Italy) is a leading CDMO provider, with a focus on complex small molecules and natural derivatives.
Last week, Jaguar Health announced that the Drug and Pharmacy Division of the Government of Puerto Rico Health Department has approved the registration of Mytesi® (crofelemer 125 MG delayed-release tablets), Jaguar’s FDA-approved drug product indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART). Napo Pharmaceuticals is now able to commence marketing and selling Mytesi in Puerto Rico.
Today, Jaguar Health announced that its subsidiary, Napo Pharmaceuticals, is hosting a Facebook Live conversation at 3 p.m. Eastern tomorrow, September 27, 2019, between Mr. Josh Robbins and Mr. Mark S. King, a prominent, award-winning blogger, author, speaker, and HIV/AIDS advocate. The discussion is part of Napo's "HIV Community Conversations" series . It can be viewed on Napo's Facebook page: facebook.com/napopharma.
Jaguar Health, Inc. (JAGX), closed Thursday's trading session at $1.24, off by 3.125%, on 462,318 volume with 1,572 trades. The average volume for the last 3 months is 1,007,928 and the stock's 52-week low/high is $1.00/$91.6999969.
Sigma Lithium Resources Corporation (SGMLF)
OTC Markets, Penny Stock Hub, Northern Miner, Globe Newswire, Market Screener, Seeking Alpha, Canadian Insider, Mining.com, TradingView, and Proactive Investors reported beforehand on Sigma Lithium Resources Corporation (SGMLF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Sigma Lithium Resources Corporation is on course to becoming a premier supplier to the lithium battery industry around the world. The OTCQB-listed Company is developing a world-class, hard rock lithium deposit at its Grota do Cirilo property in Brazil, with ultra-high grade and exceptional mineralogy. Sigma shareholders include some of the top ESG (environmental, sustainability, governance) focused institutional investors globally. Sigma Lithium Resources is headquartered in São Paulo, Brazil.
Sigma plans to play a leading role in the global lithium battery supply chain and thriving electric vehicle (EV) industry. The Company manages a green and sustainable mining operation. It commissioned its Phase I pilot plant and has produced more than 100 tonnes of samples of battery grade spodumene lithium concentrate from its high-quality deposits.
Sigma has 28 mineral rights in four properties spread over 188 km2 and 18,887 hectares - with greater than 200 lithium bearing pegmatites and 11 former historical lithium mines. The Grota do Cirilo property is its main focus. Grota do Cirilo includes 10 mining concessions (mining production authorizations).
The Company is strategically located in Brazil providing high quality battery grade spodumene concentrate. Sigma is a potential low cost, high margin producer. It has first-class infrastructure and project access. The expectation is that this will result in manageable capital costs to production.
Last month, Sigma Lithium Resources announced that it participated in a public symposium held at the Municipal Chamber of Itinga with senior Federal, State and Local Brazilian government officials. The purpose of the symposium was to discuss how to further facilitate and develop the Lithium Value Chain through creating an industrial zone dedicated to the development of the lithium chemical processing in the Jequitinhonha Valley, building on Sigma’s investments in mining lithium in the region.
The projection is that Sigma will produce 220,000 tonnes per year of high-quality battery-grade 6 percent lithium oxide concentrate, or spodumene, with one of the lowest levels of impurities in the world, which according to the studies completed thus far will likely be one of the lowest-cost lithium mine operations worldwide.
Today, Sigma Lithium Resources announced that it participated in a Panel at the Financial Times Commodities Americas Summit 2019 in Rio de Janeiro, Brazil. There, executives discussed the future of the mining industry in the Americas and the adoption of higher standards of environmental sustainability practices.
Ana Cabral, Sigma Chief Strategy Officer, said at the panel, “Sigma Lithium was already born green back in 2013, in order to secure a leading position in supplying the environmentally-focused electric vehicle value chain. As a result, we committed 15 percent of our Capex to environmental equipment and technologies that would keep Sigma at the forefront of environmental best practices, including efficient water usage through recirculation and dry stacking tailings management.”
Sigma Lithium Resources Corporation (SGMLF), closed Thursday's trading session at $1.4395, even for the day, on 100 volume. The average volume for the last 3 months is 767 and the stock's 52-week low/high is $1.19000005/$1.66999995.
TearLab Corporation (TEAR)
Zacks, MacroTrends, TipRanks, Simply Wall St, Nasdaq, Market Screener, GlobeNewswire, Investing.com, Morningstar, BioSpace, and TMXmoney reported earlier on TearLab Corporation (TEAR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, TearLab Corporation develops and markets lab-on-a-chip technologies. These technologies enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The Company’s mission is to pioneer the future of tear film diagnostics to elevate patient care. TearLab is headquartered in Escondido, California.
The TearLab Osmolarity Test is for diagnosing Dry Eye Disease. It is the first assay developed for the award-winning TearLab Osmolarity System. The TearLab Osmolarity System is a proprietary in vitro diagnostic tear testing platform. It measures tear film osmolarity for the diagnosis of dry eye disease. It also enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care.
The Company’s TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab pen, a hand-held device that interfaces with the TearLab disposable; and TearLab reader, a small desktop unit that allows for the docking of the TearLab pen, and also provides a quantitative reading for the operator.
Last month, TearLab reported its consolidated financial results for Q2 ended June 30, 2019. The Company grew quarterly Revenue sequentially to $5.9 million, a $0.2 million increase versus the first quarter of 2019. TearLab had a Cash position of $9.2 million as of June 30, 2019, an increase from $8.9 million as of March 31, 2019 and $8.5 million as of December 31, 2018. It expanded the U.S. active device base to 4,811 TearLab Osmolarity Systems.
TearLab’s reported Net Loss for the 2019 second quarter was roughly $1.2 million, or ($0.10) basic loss per share, versus a reported Net Loss of roughly $0.7 million, or ($0.06) basic loss per share in Q2 of 2018.
Seph Jensen, TearLab’s Chief Executive Officer, said, “We were pleased to deliver revenue growth over prior quarter, capitalizing on the current market momentum for osmolarity and growing our customer base. In the second quarter of 2019, we continued to strengthen our cash position and work diligently on the resubmission of our 510(k) application to secure FDA clearance of our next-generation TearLab Discovery™ System.”
TearLab Corporation (TEAR), closed Thursday's trading session at $0.055, up 1.1029%, on 14,500 volume with 4 trades. The average volume for the last 3 months is 32,650 and the stock's 52-week low/high is $0.029999999/$0.200000002.
Valeritas Holdings, Inc. (VLRX)
Zacks, Alpha Stock News, StockTwits, Stocks Equity, StocksBeat, Proactive Investors, Infront Analytics, Investors Observer, AI Stock Finder, Stockwatch, Stockhouse, MacroTrends, and Nasdaq Trader reported earlier on Valeritas Holdings, Inc. (VLRX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Valeritas Holdings, Inc. is a medical technology company and maker of the V-Go® Wearable Insulin Delivery device that uses its proprietary h-Patch™ technology. A commercial-stage medical technology enterprise, its emphasis is on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. The Company sells V-Go® to third-party wholesalers and medical supply distributors. Valeritas Holdings is headquartered in Bridgewater, New Jersey. The Company operates its R&D functions in Marlborough, Massachusetts.
The V-Go® Wearable Insulin Delivery device is its flagship product. V-Go® is a simple, affordable, all-in-one basal-bolus insulin delivery option for patients with type 2 diabetes. It is worn like a patch and can eliminate the need for taking numerous daily shots. V-Go administers a continuous pre-set basal rate of insulin over 24 hours. In addition, it provides discreet on-demand bolus dosing at mealtimes.
V-Go is the only basal-bolus insulin delivery device on the contemporary market specifically designed keeping in mind the needs of type 2 diabetes patients. V-Go is cleared for use in the U.S. and the E.U. It is commercially available in the U.S.
Valeritas is developing two next generation single-use disposable V-Go devices - V-Go PreFill™ and V-Go SIM™. V-Go PreFill™ will enable the Company to sell V-Go along with the insulin in one commercial product. It will feature a prefilled insulin cartridge that the patient can snap into the V-Go device eliminating the insulin-filling process.
V-Go SIM™ will feature one-way communication to smart devices by way of RF/Bluetooth technology. V-Go Link™ will provide real-time tracking information of basal and bolus dosing utilization.
This week, Valeritas Holdings announced that positive data from its preclinical pharmacokinetic (PK) study of cannabidiol (CBD) subcutaneous infusion was presented on September 24th at the CannMed Conference in Pasadena, California. Valeritas believes this study represents the first report of CBD delivered through subcutaneous infusion in any preclinical model.
In the poster presentation titled “Pharmacokinetic Study of Subcutaneous Infusion of Cannabinoid (CBD) Isolate in Dogs via the h-Patch™ Wearable Device,” the data demonstrated rapid and robust absorption and distribution of 40mg of CBD delivered over 24 hours with the h-Patch™ technology. CBD was detected within one hour of the start of infusion, followed by prolonged elimination with near steady-state levels still detectable 24 hours after completion of h-Patch™ infusion, or 48 hours in total.
Valeritas’ h-Patch™ is a drug delivery technology. It can facilitate the simple and effective subcutaneous delivery of injectable medicines to patients across a wide spectrum of therapeutic areas. Valeritas’ V-Go is the first FDA-approved (Food and Drug Administration) product that uses the h-Patch™ technology. To date, greater than 20 million V-Go insulin delivery devices have been sold in the U.S. Today, Valeritas Holdings announced that Dr. Jessica Barnes, consultant to the Company, will be a panelist at CBD Expo EAST 2019 taking place November 15-16, 2019, at the Hilton Orlando in Orlando, Florida.
Valeritas Holdings, Inc. (VLRX), closed Thursday's trading session at $1.46, off by 2.6667%, on 103,268 volume with 445 trades. The average volume for the last 3 months is 574,514 and the stock's 52-week low/high is $1.45000004/$33.2000007.
Cyber Security 1 AB (CYBNY)
Stockhouse, GlobeNewswire, Seeking Alpha, TradingView, Morningstar, TeleTrader, Dividend Investor, 4-Traders, YCharts, and GuruFocus reported earlier on Cyber Security 1 AB (CYBNY), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Cyber Security 1 AB is an international leader in Cyber Security. The Company provides cyber resilience solutions and conducts its operations through physical presences in Sweden, South Africa, the United Kingdom (UK), Kenya, Germany, Austria, Turkey, Greece, Italy, the Ukraine and the United Arab Emirates (UAE). The Company formerly went by the name Cognosec AB (publ). It changed its name to Cyber Security 1 AB in July of 2018. Cyber Security 1 AB is based in Stockholm, Sweden. The Company lists on the OTC Markets Group’s OTCQX.
Providing governance, risk, and compliance cybersecurity solutions, Cyber Security 1 provides solutions for client and information systems audit, penetration testing, application security assessment, and security monitoring. In addition, the Company provides solutions for urgent incident response and crisis management, data leakage and loss prevention, and network security and management.
Cyber Security 1 has a growing international footprint, an impressive client list, a flourishing mergers and acquisition (M&A) strategy and in 2019 a newly appointed Chief Executive Officer (CEO). Furthermore, Cyber Security 1 had revenues of 44.54m EUR in 2018 and employed 239 personnel at the end of Q4 2018.
Cyber Security 1 announced earlier this year an exclusive five-year partnership with Formula 1®, the world’s premier motorsport series. It will provide Formula 1® with an assortment of resilient solutions, designed to enhance and secure Formula 1’s infrastructure from potential cyber threats. Cyber Security 1 will work closely with the Information Technology (IT) department at Formula 1®, delivering a number of key projects. This includes consultancy, implementation, and advisory.
Cyber Security 1 announced this past March the signing of exclusive Heads of Terms of Agreement pursuant to the acquisition of IntaForensics. Since IntaForensics’ formation in 2006, the business has grown worldwide to provide the widest variety of Digital Forensic and Cyber Security Services from its England headquarters.
IntaForensics is one of the fastest growing Digital Forensic Services providers globally. It is one of a few organizations that possesses the prestigious ISO/IEC 17025 Laboratory Standard. Additionally, it is accredited to ISO/IEC 27001 and ISO 9001. The business is accredited by the PCI Security Standards Council as a Qualified Security Assessor and a PCI Forensics Investigator (QSA, PFI).
Recently, Cyber Security 1 reported its H1 2019 results. Selected highlights include Total Revenue growth increasing by 267.7 percent, from 9.01m EUR H1 2018, to 33.13m EUR H1 2019. Organic Revenue (excluding 2018 acquisitions) rose by 121 percent, from 9.01m EUR H1 2018, to 19.91m EUR H1 2019. Group Gross Margin rose 86.8 percent, from 3.71m EUR H1 2018, to 6.93m EUR in H1 2019.
Cyber Security 1 AB (CYBNY), closed Thursday's trading session at $1.40, up 54.4402%, on 100 volume with 1 trade. The average volume for the last 3 months is 37 and the stock's 52-week low/high is $0.906499981/$3.86999988.
Metrospaces, Inc. (MSPC)
Stockwolf, Investors Hangout, Street Insider, Penny Stock Tweets, Stockhouse, Stock of the Week, InvestorsHub, OTC Markets, ClayTrader, Small Cap Network, Insider Financial, Barchart, WalletInvestor, MarketWatch, Emerging Growth, and Street Register reported earlier on Metrospaces, Inc. (MSPC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Metrospaces, Inc. is a real estate investment and development Company. It acquires land, designs builds, and develops, then resells condominiums and Luxury High-End Hotels, chiefly in urban areas of Latin America. The Company is operated by a premier group of real estate and investment professionals and entrepreneurs located in New York, New York; Miami, Florida; and Buenos Aires, Argentina. Metrospaces’ current projects are in Buenos Aires, Argentina, and Caracas, Venezuela.
A start-up real estate private equity firm, Metrospaces is based in New York City. The Company’s refocusing of its business plan to U.S.-based projects is now complete. Metrospaces has strong relationships with Investment Bankers, Real Estate Entrepreneurs, Political Leaders and High Net-Worth Individuals around the world. The Company’s focus is on mid-sized deals.
Metrospaces looks to use its international relationships in financing and real estate developers to find co-investment and development opportunities in home building, residential and hotel. Furthermore, it will invest in operating companies that are real estate based. This includes hotel operators and senior facilities operators. Metrospaces will also invest in corporate reorganization.
The Company focuses on joint ventures (JV’s) with established players. Metrospaces’ majority shareholders have partnered with Investors on elite properties including The London BLVGARI 5 Star Hotel and are presently involved in negotiations for the development of a number of elite luxury properties in South America.
Metrospaces has executed a JV Agreement with Prohotels of Argentina. The agreement calls for the development of four new hotels in the coming three years.
Recently, Metrospaces announced a management decision to focus capital resources to its Cannabis-related real estate Company, CannPartners. At present, Metrospaces is looking at two properties, one in Connecticut and one in California. The Company is also keeping a strong focus on the New York market. It is in advanced talks for acquisition of those properties.
Mr. Oscar Brito, Metrospaces Executive President, said, “The continuing legalization of medical and recreational cannabis growing and distribution will continue in the US for the foreseeable future. Many investors are focusing on the grow, distribution and ancillary industries such as paraphernalia etc. However, even with the billions of dollars currently being invested in the cannabis industry, there are very few institutional investors solely focusing on the cannabis-related real estate side of the business. In our opinion, this represents a once-in-a-generation opportunity to buy distressed and real estate located in out-of-favor locations across the U.S.”
Metrospaces, Inc. (MSPC), closed Thursday's trading session at $0.0001, even for the day, on 30,266,998 volume with 17 trades. The average volume for the last 3 months is 9,919,205 and the stock's 52-week low/high is $0.000000999/$0.0006.
ReelTime Rentals, Inc. (RLTR)
MarketWatch, Stockhouse, Marketwired, WalletInvestor, Penny Stock Hub, Barchart, Simply Wall St, Penny Stock Tweets, 4-Traders, InvestorsHub, and OTC Markets reported on ReelTime Rentals, Inc. (RLTR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
ReelTime Rentals, Inc. (d/b/a ReelTime VR, ReelTime Media Group) is a multimedia publishing business. The Company engages in helping individuals that have been thrust into the public eye to monetize their exposure and control the portrayal of their story. In addition, it develops, produces, and distributes Virtual Reality (VR) Content and technologies under the brand ReelTime VR. ReelTime is headquartered in Seattle, Washington and lists on the OTC Markets.
ReelTime has end to end production, editing, and distribution capabilities for internal and external projects. At present, the Company produces three ongoing series for the Samsung Gear VR platform, VeeR TV, Oculus. It distributes them over manifold VR delivery sites.
Regarding Partnerships, ReelTime partners with other top VR distributors, content producers, and technology providers. Furthermore, concerning its Services, the Company offers Consulting, Production, Monetization, VR Set Design, VR Media Campaigns, as well as VR Content Production.
Pertaining to VR Set Design, ReelTime has a totally-dressed virtual set in its studio facilities. It can create any look one wants for their Virtual Reality show. Also, it can provide traditional virtual set backdrops.
Concerning VR Content Production, ReelTime has a team of editors and other pre/post-production professionals available for all elements of producing VR content. This is from the initial design concepts, to pixel-perfect deliverables.
ReelTime VR announced recently that it became the first to utilize a proprietary technology developed by the Company that allows it to film in full 360 x 360 Virtual Reality formats and simultaneously film in formats compatible with traditional Television platforms. This will allow ReelTime VRs shows the Company produces to not only be available on the rapidly growing premium VR sites it is currently available on, but it will additionally be available for distribution over mainstream Network Television formats and worldwide.
ReelTime has received patent-pending status from the United States Patent and Trademark Office (USPTO) for its non-provisional patent application encompassing apparatus and method claims for technology involving simultaneous capturing of 360 X 360-degree Spherical Panorama Images and Video. The technology will enable any cell phone or other camera to promptly capture 360 X 360 Virtual Reality Video or pictures without any need for stitching.
The VR content is compatible with and can be shared through 360 capable social sites in real time, and on any professional VR platform such as Oculas, Gear VR, Veer VR, Playstation VR, Littlstar, and the HTC Vive.
ReelTime will start using this inventive technology in its production of its award-winning Virtual Reality travel series “In Front of View”. The series commenced filming its second season in Thailand in July. It is shot in English and in Thai. Moreover, ReelTime VR is entertaining licensing agreements with select other VR, film, and TV producers to allow them to also gain a competitive advantage.
ReelTime Rentals, Inc. (RLTR), closed Thursday's trading session at $0.0078, up 39.2857%, on 44,360 volume with 5 trades. The average volume for the last 3 months is 16,117 and the stock's 52-week low/high is $0.002799999/$0.024499999.
Inspyr Therapeutics, Inc. (NSPX)
BUYINS.NET and Zacks reported earlier on Inspyr Therapeutics, Inc. (NSPX), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Inspyr Therapeutics, Inc. is a clinical-stage biotechnology company based in Westlake Village, California. It is developing novel prodrug therapeutics for the treatment of cancer. Mipsagargin is its lead agent. Mipsagargin is in human clinical trials for patients’ with numerous different tumor types. Inspyr Therapeutics’ team has considerable pharmaceutical industry and scientific experience.
The Company lists on the OTC Markets Group’s OTCQB. It previously went by the name GenSpera, Inc. It changed its name to Inspyr Therapeutics, Inc. in August of 2016.
Mipsagargin (G-202) is a prodrug in human clinical trials for patients with hepatocellular carcinoma (HCC, or liver cancer), glioblastoma (GBM, or brain cancer) and prostate cancer. Mipsagargin has been studied in a Phase 2 clinical trial in patients with hepatocellular carcinoma (liver cancer). It has been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in this indication.
Mipsagargin is now undergoing evaluation in an open-label, single-arm, Phase II clinical study in patients with glioblastoma (brain cancer). In addition, it is undergoing evaluation in two Phase II clinical pilot studies in patients with prostate and clear cell renal cancer.
Inspyr Therapeutics has started the second development program for Mipsagargin as part of a combination therapeutic approach. This new program centers on the treatment of gastric cancer.
Inspyr has started a preclinical study in gastric cancer PDX tumor models that express varying levels of PSMA, the target of Mipsagargin. In this initial study, Mipsagargin will undergo evaluation initially in combination with paclitaxel.
Inspyr Therapeutics is developing a novel technology platform. This platform combines a strong therapeutic (thapsigargin) with a patented prodrug delivery system that targets the release of drugs within solid tumors without the side effects of chemotherapeutic agents. This unique platform technology has the potential to work across a range of drugs that precisely target different cancers.
In October of 2017, Inspyr Therapeutics announced the start of a new investigator-sponsored preclinical study of its proprietary adenosine receptor modulator (ARM) based compounds. The preclinical study is led by Elizabeth Kang, M.D., of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This study will assess these compounds for the prevention of graft versus host disease (GvHD), a potential side effect of allogeneic stem cell transplants.
Inspyr Therapeutics, Inc. (NSPX), closed Thursday's trading session at $0.0045, up 28.5714%, on 1,316,587 volume with 5 trades. The average volume for the last 3 months is 371,076 and the stock's 52-week low/high is $0.002199999/$0.01305.
Natcore Technology, Inc. (NTCXF)
Stockhouse, InvestorsHub, MarketWatch, OTC Markets, Business Insider, and StreetInsider reported on Natcore Technology, Inc. (NTCXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Natcore Technology, Inc. concentrates on using its proprietary Foil Cell technology to considerably lower the costs and improve the power output of solar cells. The Company is creating the next generation of solar cells. Natcore is developing two main technologies. These are low-cost, all-back-contact solar cell structures, and Black Silicon cells.
A solar R&D company, Natcore Technology is headquartered in Rochester, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.
The Company’s Foil Cell (All Back Contact Solar Cell) uses a high-speed, low temperature laser process. Natcore’s Black Silicon technology streamlines the path to low solar cell reflectance.
Natcore Technology has its Natcore Laboratory in Rochester. This is a 19,000 sq. ft. facility. It has 8,000 sq. ft. of ‘class 10,000’ clean room. The Company engages in the full solar cell process at this laboratory - from bare silicon wafer to working cells.
Regarding the Company’s Foil Cell Structure, the process involves multilayer foil metallization. Key features/properties include low cost contact metals and simplified manufacture. This includes low capital equipment cost, small factory footprint, and low temperature processing.
Natcore Technology has established exclusive licenses and/or joint research agreements with Rice University, the National Renewable Energy Laboratory (NREL), Fraunhofer ISE and the University of Virginia. The Company has received 33 patents; 32 patents are pending.
Recently, Natcore Technology announced it significantly streamlined the fabrication method for its pioneering Natcore Foil Cell™. This allows for even lower-cost production methods.
The Company is targeting greater than 25 percent real-world efficiency for its eventual production solar cells. This is approximately a 25 percent performance improvement over numerous high-end commercial cells being installed today.
The use of laser processing to create the Company’s unique, all-back-contact cell structure has been eliminated and replaced by a carrier selective contact process. This is combined with a foil metallization, which can be inexpensively made with high-speed roll-processing methods. Natcore has started an accelerated development program to produce a prototype with the new process, and also include production cost and efficiency modeling by independent authorities.
Natcore Technology, Inc. (NTCXF), closed Thursday's trading session at $0.0264, up 61.9632%, on 27,000 volume with 2 trades. The average volume for the last 3 months is 17,576 and the stock's 52-week low/high is $0.001099999/$0.115000002.
Atacama Resources International, Inc. (ACRL)
MarketWatch and OTC Markets reported on Atacama Resources International, Inc. (ACRL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Atacama Resources International, Inc. has significant mining claims in the greater Kirkland Lake area of Northern Ontario. Metals and minerals under potential exploration include gold, silver, diamonds, graphite and cobalt. Furthermore, major deposits of copper and iron ore are included in the mining claims. Atacama Resources International is headquartered in Plantation, Florida.
Regarding Minerals, the Company has numerous claims on 4460 acres in the Kirkland Lake and other areas of mineral-rich northern Ontario. The Company’s initial line of business is a combination of mining, acquisition, as well as development of mining interests in the Kirkland Lake region.
Atacama Resources International announced last September that it engaged Canadian Exploration Services Ltd. (CXS) to conduct a geological evaluation of the Company’s Cabo property. The Cabo property comprises Mining Claim 4225513, located in the Township of Lorrain in the heart of all the high-profile cobalt activity surrounding the historic mining town of Cobalt, Ontario.
Atacama Resources has acquired the mineral rights for the Mystery Graphite Property that comprises 1740 acres situated roughly 60 miles south of Timmins, Ontario. The acquisition of the mineral rights includes receiving core samples collected from numerous diamond drill sites earlier conducted on the property.
Additionally, Atacama Resources is involved in a new line of business that it states will make the highways of the U.S. and Canada safer and saves lives in the process. The Company, as part of its expansion portfolio, acquired Good2Drive™, Inc. Good2Drive, Inc. is a wholly-owned subsidiary of Atacama Resources International.
Good2Drive™ is an entity that has the rights to an application (app), which detects levels of cognitive awareness and reports those levels in accordance with the users' demands and needs. The Company’s technology business includes the innovative Smartphone application Good2Drive and also follow on products that will be released this year.
Atacama Resources International released Good2Drive in 2017. Good2Drive is a mobile application that enables drivers, corporate fleets, and law enforcement to test a driver's cognitive alertness before getting behind the wheel of a motor vehicle. Good2Drive uses a 60-90 second image matching test using a patented algorithm that was created based on the scientific study of cognitive abilities at different West Coast hospitals and universities.
Good2Drive’s dedication is to providing Smartphone hosted applications founded on its proprietary testing for cognitive awareness. Its set of Smartphone hosted apps will include cognitive tests for care givers, seniors with impairments, remote employees in potentially hazardous environments, and other situations where it is necessary to be cognitively alert.
Atacama Resources International also has its Good2Drive/Fleet. This is a mobile application. It enables commercial fleet owners and operators to manage manifold drivers as they test their mental alertness before getting behind the wheel of a vehicle.
Recently, Atacama Resources International announced that it released ‘Fit4Duty’. This is a mobile application that permits companies to test cognitive alertness for its employees before getting behind the wheel of a company vehicle and for employees working in potentially hazardous work assignments. Fit4Duty includes a 60-90 second image matching test utilizing a patented algorithm.
Atacama Resources International, Inc. (ACRL), closed Thursday's trading session at $0.01025, up 18.0876%, on 5,243,530 volume with 133 trades. The average volume for the last 3 months is 6,824,114 and the stock's 52-week low/high is $0.000199999/$0.0215.
Andrea Electronics Corp. (ANDR)
Stock Guru reported earlier on Andrea Electronics Corp. (ANDR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Andrea Electronics Corp. designs, develops, and manufactures audio technologies and equipment for enhancing applications necessitating high performance quality voice input. The Company is an innovator of digital audio input enhancement software, computer headsets, and array microphone technologies. In addition, it is an industry leading developer of product solutions that optimize the performance of voice user interfaces for different applications. Andrea Electronics is based in Bohemia, New York, it lists on the OTCQB.
Andrea’s patented Digital Super Directional Array (DSDA™), patented PureAudio™, and patented EchoStop™ far-field microphone technologies enhance a wide variety of audio products to eliminate background noise and ensure the optimum performance of voice applications. The Company’s products include Array Microphones, Active Noise Cancellation Microphone Headsets, USB Headsets, Headphones, Computer Microphones, USB Audio Adapters, Noise Reduction Software, and Echo Cancellation Software, which betters the performance and provides ease of use for applications.
These applications include Speech Recognition, Voice over the Internet (VoIP), Video conferencing, Game chat, and live digital audio recordings. Among the more recent advances from Andrea Electronics are SuperBeam Stereo Array Microphone headsets and the DA-250 digital microphone stand alone solution for original equipment manufacturers (OEMs).
Andrea Electronics has its Go Mic Connect, USB stereo array microphone with the Company’s audio enhancement software. This bundle is the most adaptive digital microphone on the market. The design of the Company’s latest filter libraries is for OEMs targeting new product platforms running Linux and Android operating systems. This is while using new strong mobile processors with DSP cores, including ARM.
The Andrea PC Audio Software (AudioCommander™) provides the latest Audio Commander and noise cancellation filters for use with all Andrea USB Devices. The install supports Windows.
Recently, Andrea Electronics announced that it is suing Apple, Inc. for patent infringement on audio processing technology found in the defendant's products. The hearing at the U.S. International Trade Commission in Washington, DC is set to commence today, August 21, 2017.
Mr. Douglas Andrea, Chief Executive Officer of Andrea Electronics, said, "We are a proud, third-generation family business whose products are showcased in the Henry Ford Museum and the Smithsonian National Museum, and we refuse to stand by and watch a legacy built over 80 years to be torn down by electronic giants with deep pockets and global influence. We are proud that Apple, like our already existing licensees, desires the use of our technology, but we request that they license it legally. If they refuse, we ask that the ITC stop them from selling products that contain our patented technology."
Andrea Electronics Corp. (ANDR), closed Thursday's trading session at $0.0389, up 35.5401%, on 6,000 volume with 1 trade. The average volume for the last 3 months is 38,051 and the stock's 52-week low/high is $0.028699999/$0.079999998.
The QualityStocks Company Corner
- Xalles Holdings Inc. (OTC: XALL)
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
- Nightfood Holdings, Inc. (OTCQB: NGTF)
- Spectrum Global Solutions, Inc. (SGSI)
- Trxade Group Inc. (TRXD)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- Pressure BioSciences Inc. (PBIO)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- ChineseInvestors.com (CIIX)
- VPR Brands, LP (VPRB)
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
- B2Digital Inc. (OTC: BTDG)
- Neutra Corp. (OTCQB: NTRR)
Xalles Holdings Inc. (OTC: XALL)
Xalles Holdings Inc. (OTC: XALL) today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community. The interview can be heard at http://nnw.fm/ymz2L.
Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.
The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.
Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.
All current subsidiaries are wholly owned
- Xalles Holdings
Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
- Xalles Capital
Management support of investment consortiums, direct investment into funds or projects, and management of investments
- Xalles Limited
Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
- Xalles Technology
Technical development of the X2X blockchain systems
- Xalles Financial Services
Consumer and small business financial service offerings
- Co-Owners Rewards
Stock-based rewards system for payments cards and financial services
- Amazing Living Enterprises
Affiliate program and e-commerce platform for enhancing financial lives
- Global Savings Network
Not-for-profit fundraising system with consumer discounts at local merchants
Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.
Advancements in 2019
- Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
- Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
- Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.
“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”
– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)
Xalles Holdings Inc. (OTC: XALL), closed Thursday's trading session at $0.004065, up 1.625%, on 251,139 volume with 7 trades. The average volume for the last 3 months is 3,175,063 and the stock's 52-week low/high is $0.0013/$0.021029999.
- Xalles Holdings Inc. Discusses its Blockchain Technology in Exclusive Audio Interview
- Xalles Holdings Inc. (XALL) Achieves Five Consecutive Revenue-Producing Quarters
- Coverage Initiated for Xalles Holdings Inc. via NetworkNewsWire
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to provide shareholders with comments on the passage yesterday of the Secure and Fair Enforcement Banking Act of 2019 (SAFE Banking Act) by the United States House of Representatives.
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.
Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.
- Investment and funding for rapid growth
- Vertical integration solutions
- Construction, design and/or optimization of indoor or outdoor cultivation facilities
- Reputation management & influencer outreach
- Branding and Packaging
- Social Media and Media outreach
With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.
Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.
Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.
Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."
Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.
Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).
Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.
Chemistree Technology Inc. (CHMJF), closed Thursday's trading session at $0.16, up 23.0769%, on 4,720 volume with 11 trades. The average volume for the last 3 months is 26,720 and the stock's 52-week low/high is $0.097000002/$0.605000019.
- Chemistree Applauds Initial Success for Safe Banking Act in U.S.
- Chemistree Provides Washington State Update from Sugarleaf
- 420 with CNW – Radio Frequency Technology Tweaked to Protect Marijuana Quality
Nightfood Holdings, Inc. (OTCQB: NGTF)
Nightfood Holdings (OTCQB: NGTF), the fast-growing ice cream company addressing America’s $50 billion nighttime snacking problem, this morning announced that its products have officially hit the shelves in various locations of its newest supermarket chain distribution partner. To view the full press release, visit: http://nnw.fm/s25xX
Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.
Nightfood Ice Cream
Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.
Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.
With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.
Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.
More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.
Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.
Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.
Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.
Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.
MJ Munchies, Inc.
MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.
Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.
Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.
Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.
CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.
The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.
Nightfood Holdings, Inc. (NGTF), closed Thursday's trading session at $0.35, up 16.6667%, on 194,171 volume with 64 trades. The average volume for the last 3 months is 125,623 and the stock's 52-week low/high is $0.160099998/$0.920000016.
- Nightfood Holdings Inc. (NGTF) Products Spotted on Shelves in New Supermarket Chain
- Nightfood Delivers Update on Recent Activities and Developments
- Sports Influencers and Consumer Branding - It's a Win-Win
Spectrum Global Solutions, Inc. (SGSI)
Spectrum Global Solutions (OTCQB: SGSI), a leading single-source provider of next-generation communications network infrastructure and maintenance solutions, this morning announced that it has forced the conversion of over $800,000 in convertible seller notes that were issued in 2018 into common stock. To view the full press release, visit http://nnw.fm/np34D.
Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:
- AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
- ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
- Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.
Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.
Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.
CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.
Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.
Spectrum Global Solutions, Inc. (SGSI), closed Thursday's trading session at $0.02488, up 8.1739%, on 405,113 volume with 27 trades. The average volume for the last 3 months is 176,427 and the stock's 52-week low/high is $0.014999999/$1.49.
- Spectrum Global Solutions Inc. (SGSI) Cuts More Than $800 Thousand in Convertible Debt
- Spectrum Global Solutions Inc. (SGSI) Prepared to Support 5G Technology
- Spectrum Global Solutions Inc. (SGSI) Prepared for Next Generation 5G Communication Services
Trxade Group Inc. (TRXD)
Growing competition and the consolidation of corporate pharmacy chains are two of the biggest challenges that small and independent pharmacies have to overcome. Companies like Trxade Group Inc. (OTCQB: TRXD) are working on the development of technological solutions that will enable small industry players to remain competitive.
Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.
Trxade will leverage and scale its fully integrated model to execute the following growth strategies:
- Increase share of pharmacist drug purchasing
- Additional SKUs and expand product breath
- Partner with Specialty and International Mfg.
- Expand mail order licenses to all 50 states
- Scale Delivmeds for consumer delivery nationwide
- Integration with telemedicine
- M&A Opportunities within drug value chain
Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.
The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.
Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.
Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!
Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.
The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.
Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.
These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.
Health Care Market
The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.
Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.
Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.
TRxADE's programs include:
- TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
- RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
- Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.
Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.
Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.
Trxade Group Inc. (TRXD), closed Thursday's trading session at $1.44, even for the day, on 25 volume with 1 trade. The average volume for the last 3 months is 3,592 and the stock's 52-week low/high is $0.230000004/$1.60000002.
- Trxade Group Inc. (TRXD) Equipping Community Pharmacies with the Tools Needed to Overcome Their Biggest Challenges
- Tech Solutions Like Those from Trxade Group Inc. (TRXD) Can Help Independent Pharmacies Thrive in the Future
- Trxade Group Inc. (TRXD) Achieves Record Revenues, Advances Strategic Initiatives
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was highlighted today on national TV Sat. Sept. 28 & Sun. Sept. 29, 2019 - As the Canadian cannabis sector remains strong, BTV- Business Television visits thriving opportunities ripe for investment. BTV, a half-hour weekly investment program, profiles emerging companies across Canada and the US to bring investors information for their portfolio. Also today, the company was highlighted in a publication from Motley Fool, examining how the biggest marijuana day of the year is exactly three weeks away. On Oct. 17, 2019, marking the one-year anniversary since recreational marijuana sales commenced in Canada, rules governing the sale of derivative pot products will officially go into effect.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Thursday's trading session at $3.69, off by 2.8947%, on 1,438,729 volume with 4,624 trades. The average volume for the last 3 months is 1,070,928 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- BTV Uncovers Companies in the Growing Cannabis Sector
- 3 Brand-Name Cannabis-Infused Beverage Stocks You Need to Know
- One of the Largest Licensed Cannabis Producers in Canada
Pressure BioSciences Inc. (PBIO)
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its patented pressure cycling technology (“PCT”) platform was prominently featured at the International Human Proteome Organization World Congress (“International HUPO”) in no less than ten separate presentations from scientists affiliated with seventeen leading research institutions worldwide. To view the full press release, visit http://nnw.fm/b8P6s.
Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.
The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.
Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”
Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.
The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.
Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.
This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.
The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.
Pressure BioSciences Inc. (PBIO), closed Thursday's trading session at $2.72, off by 2.509%, on 7,084 volume with 25 trades. The average volume for the last 3 months is 11,734 and the stock's 52-week low/high is $1.25/$4.0999999.
- Pressure BioSciences Inc.’s (PBIO) Patented PCT Platform Highlighted in 10 Separate Presentations at International Human Proteome Organization World Congress
- Pressure BioSciences Inc.’s (PBIO) Proprietary Technology Platform Identified as Key Cancer Biomarker Research Element
- Pressure BioSciences Inc. (PBIO) Issues Update on Guidance for Revenue Growth and Success of Revolutionary CBD Oil Processing System
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was featured today in the 420 with CNW by CannabisNewsWire. The UK government has legalized the use of medical marijuana; however, accessing it is next to impossible. This has prompted professors, doctors, health experts, and politicians to sign letters petitioning the government to make medical marijuana free to all patients. To access medical marijuana for free, patients have to present a prescription from the NHS (National Health Service), which serves as the United Kingdom’s comprehensive, universal, and free-at-the-point-of-service system of medication.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed Thursday's trading session at $1.77, off by 3.1464%, on 528,713 volume with 605 trades. The average volume for the last 3 months is 659,010 and the stock's 52-week low/high is $1.60699999/$5.80000019.
- 420 with CNW – UK Experts Want Medical Marijuana Free for All
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Confirms Robust Demand for Premium Organic Cannabis
- The Green Organic Dutchman Hosts Analyst Site Visit at Hamilton and Valleyfield Facilities
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF)today announced that Jann Parish, Chief Marketing Officer, has been named to the Forbes CMO Next list, a list comprised of 50 individuals considered to be leading the way as disruptive chief marketers. To view the full press release, visit http://cnw.fm/Y0kkr.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Thursday's trading session at $1.0429, off by 6.0873%, on 201,502 volume with 214 trades. The average volume for the last 3 months is 401,800 and the stock's 52-week low/high is $1.03639996/$5.20499992.
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Chief Marketing Officer Recognized on Forbes CMO Next List
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) to Report Results, Host Earnings Conference Call for Q4 and Fiscal Year 2019
- Green Growth Brands to Hold Fourth Quarter and Fiscal Year 2019 Earnings Conference Call on October 24, 2019
ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang said in a MoneyTV interview with host Donald Baillargeon that he was pleased with the reaction to the company’s presentation at the MicroCap Conference, held recently at the Essex House in New York. The presentation was given by Alex Hamilton, CFO of CIIX subsidiary Biotech CBD Inc. (http://cnw.fm/x5iZm).
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Thursday's trading session at $0.26, off by 5.4545%, on 32,620 volume with 11 trades. The average volume for the last 3 months is 46,757 and the stock's 52-week low/high is $0.25/$1.25.
- ChineseInvestors.com Inc. (CIIX) MicroCap Presentation Well Received, CBD Future Bright
- ChineseInvestors.com Inc. (CIIX) Announces 175% Sales Increase, Launch of Six New Hemp-Infused Skincare Products
- ChineseInvestors.com Inc. to Present September 17, 2019 at the MicropCap Conference in New York City
VPR Brands, LP (VPRB)
VPR Brands (OTCQB: VPRB), a market leader and pioneer in electronic cigarettes and vaporizers for nicotine, cannabis and cannabidiol (“CBD”), this morning announced that it will be debuting its premium GOLDLINE Hemp-Derived CBD products at the NACS Show 2019 taking place in Atlanta at the Georgia World Congress Center, October 2-4. The company will be located at booth #C5865 in the Hemp-Derived CBD Pavilion. To view the full press release, visit http://cnw.fm/R3tP8.
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Thursday's trading session at $0.042, off by 1.1765%, on 20,100 volume with 2 trades. The average volume for the last 3 months is 141,368 and the stock's 52-week low/high is $0.033799998/$0.119999997.
- VPR Brands LP (VPRB) to Debut Premier GOLDLINE CBD Products at NACS 2019
- VPR Brands LP (VPRB) Gearing Up to Launch Vape Battery Line
- VPR Brands LP (VPRB) Seeks to Protect Patented Auto-Draw Technology as Vaping Industry Booms
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3)this morning provided an update addressing the recent vaporizer product safety concerns. In the release, IONKF reiterated its concentration on safety and its commitment to self-regulating above and beyond required regulations and quality measures. To view the full press release, visit http://cnw.fm/R4ntV.
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.
With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.
IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.
Elite Brand Portfolio/Acquisitions
- IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
- WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
- ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
- Vuber Technologies hardware produces the best vaporization experience on the market.
- Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
- Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.
IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.
Experienced Management Team
IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.
Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.
Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.
Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.
Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.
In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.
IONIC Brands Corp. (OTC: IONKF), closed Thursday's trading session at $0.0388, off by 3.9604%, on 562,520 volume with 85 trades. The average volume for the last 3 months is 259,742 and the stock's 52-week low/high is $0.032000001/$0.634559988.
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Temporarily Suspends Production in California Amid Vape Product Safety Concerns
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Secures DTC Eligibility for U.S. Markets
- IONIC BRANDS Announces DTC Eligibility for the U.S. Markets
B2Digital Inc. (OTC: BTDG)
B2Digital (OTC: BTDG) today announced that the Pinnacle Combat Fight Group will make its B2 Fighting Series debut at the Pinnacle Combat 31 event on September 28 at McGrath Dubuque Harley-Davidson in Dubuque, Iowa. To view the full press release, visit http://nnw.fm/7Bf1U.
B2Digital Inc. (OTC: BTDG) is applying its extensive background in entertainment, television, video and technology to become a full-service live event sports company. Capitalizing on its strong management team, industry relationship, and hands-on experience in the industry, B2Digital is developing and acquiring Mixed Martial Arts (MMA) and sports-related companies to build an integrated premier development league initially for the billion-dollar MMA marketplace.
B2Digital’s management team boasts over 30 years of combined global experience developing more than 20 companies within the sports, television, entertainment, digital distribution and banking transaction industries.
Since its restructuring in 2017, the company is now forging ahead with company chairman and CEO Greg P. Bell at the helm. His expertise, relationships and experience bring a background of more than 40,000 successful live events throughout his career. Under his guidance, B2Digital will create and develop the “Development League” champions that will move on to the MMA major leagues from within the B2 Fighting Series.
In preparation, B2Digital has produced and applied the systems and technologies required to support and maintain infrastructural operations of the company, including: social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems. The company has also launched its B2 Social Media Network as the digital distribution system for the B2 Fighting Series.
As part of its growth strategy, B2Digital intends to continue to develop and acquire assets that meet its business model with the goal of becoming a premier vertically integrated live event sports company. In 2017, B2Digital started operating B2 Fighting Series, live MMA events; each year, the top fighters are invited to the live annual B2 Fighting Series National Championship.
B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks and branding for the B2Digital companies. The company has deployed its B2 Social Media Network digital distribution network for the B2 Fighting Series and has developed and deployed the systems and technologies for the operation of social media marketing, event engagement, digital ticketing sales, digital video distribution, digital marketing, PPV, fighter management, merchandise sales, brand management and financial control systems.
Fight Groups (holdings)
- Colosseum Combat
- United Combat League
- Pinnacle Combat
- Bluegrass MMA
B2 Social Media Network (B2SN)
The B2 Social Media Network (B2SN) provides the connection between the B2Digital live events and the consumer audience by:
- Providing social interaction between consumers regarding B2Digital Properties and current relevant topics to the live events audience
- Offering “FTV” free-to-view live and on-demand TV style broadcasts globally of B2 Digital live events
- Promoting upcoming live events
- Selling tickets to B2 live events electronically
- Promoting the fighters, athletes and participants in the B2Digital live events
Chairman and CEO Greg P. Bell
Greg P. Bell is one of the early pioneers and entrepreneurs in entertainment and digital media and has been working in the field for over 30 years. He was involved in the early creation of the technologies and algorithms that allowed analog media to be transformed into digital bits and compressed data streams and created specific business enterprises that capitalized on the creation of digital transmissions at Scientific Atlanta, Compressions Labs, VCON International and Qwest. Bell was one of the initial vice presidents of business development at Qwest Communications where he developed Qwest’s digital media company, Slingshot Networks. He then ran all operations of Slingshot, reporting to the board of directors, which managed and operated three full time studios including the creation of the broadcast studio in Staples Center, TV and news productions, live events at the Staples Center, distribution of a national television show distributed by Warner Brothers TV Distribution, online television productions and web distribution for the NFL, AFL, NBA, NHL, Boxing, Democratic Convention and live music events.
Upon leaving Slingshot in 2000, Bell founded B3 Development Group, a firm specializing in developing emerging market entertainment and media companies. Bell’s B3 Development Group founded B2 Networks in 2001 which quickly became the defacto standard for watching live PPV sporting events online. B2’s proprietary online system broadcasts live professional and collegiate sporting events online to a global audience, broadcasting over 1,000 live games per month. Bell developed and implemented a merger with B2 Networks and the America ONE Television Network where he became CEO of the combined companies. Under Bell’s direction the company, now called ONE Media Corp., launched the new ONE World Sports TV Network in North America on cable and satellite, with a pure digital end-to-end distribution system, along with continuing the company’s growth in the online distribution of sports and entertainment.
After leaving as CEO of ONE Media Corp., he currently sits as chairman of B3 Development Group, which specializes in developing and fast-tracking emerging entertainment, transaction technology and media distribution companies. Bell continues to expand his holdings and currently has business holdings in ONE Media Corp; B3 Development Gaming Group which under contract with Caymanas Park Race Track, owned by the country of Jamaica, developed Jamaica’s first all-digital state of the art pari-mutuel live sports gaming system for mobile devices and currently is operating under the brand CaymanasToGO for the Caribbean Consumers and is licensed for deployment in the USA to USA-based consumers. The B3 Gaming Group mobile device wagering system and technology allows consumers globally to watch and wager on live horse races and sporting events being held in the UK, USA, Canada and the Caribbean; B3 Gaming Services Group, a premier transaction and customer service group that offers management services to the Gaming industry in the Caribbean, B3 Networks, a premier state of the art digital broadcasting company that developed the B3 television satellite replacement technology which allows TV networks to broadcast globally on the public internet instead of satellites in broadcast quality HD & SD television. B3 Networks has deployed, and services, the B3 technology to broadcast high definition TV signals globally to cable head ends, smart phones and internet connected devices for the Jamaica Education Television Network, the Caymanas Race Track and other mobile applications globally.
Bell has worked at the top technology development companies that developed the digital technologies, which are in use today at Scientific Atlanta, Compression Labs, VCON and Qwest. He also has managed and been directly involved with over 55,000 live events in his 30-year career. He has worked with a diverse group of clients in the entertainment, sports and technology communities including the NFL, NBA, NHL, AHL, NLL, ECHL, IFL, USHL, SPHL, NCAA, NAIA, MISL, AFL, AOL, FOX, UFC, NAAFS, Bellator, WEF, the Staples Center, the Orleans Arena, Oscar De La Hoya, Barbra Streisand, and top entertainment venues, acts and actors. His clients and companies have capitalized on Bell’s knowledge of the world of entertainment, live events, sports, digital television and digital online transaction and distribution systems.
B2Digital Inc. (BTDG), closed Thursday's trading session at $0.0075, off by 6.25%, on 285,000 volume with 7 trades. The average volume for the last 3 months is 177,003 and the stock's 52-week low/high is $0.0023/$0.039999999.
- B2Digital, Inc. (BTDG) Announces Pinnacle Combat’s B2 Fighting Series Debut; Provides Business Update
- Coverage Initiated for B2Digital Inc. via NetworkNewsWire
- B2Digital (OTC: BTDG) Expands Portfolio With Acquisition of Strike Hard Productions MMA, Provides Business Update
Neutra Corp. (OTCQB: NTRR)
Neutra Corp. (OTCQB: NTRR) is a company intent on pursuing its interest in developing modern, healthy living solutions in a world that’s ever more focused on quality of life concerns and the rising costs of health care. Neutra Corp.’s initial focus was on bringing to market products derived from all natural and organic origins, as a nutraceutical firm developing natural remedies that promote the body’s ability to heal and maintain itself, when the company was founded in 2011. Also today, CBDWire released a report on the company detailing how NTRR is aiming to participate in the hemp-based CBD market through its recent strategic acquisition of Vivis Corp.
Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.
Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.
Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.
- Vivis – Neutra is expanding its market presence in the rapidly growing hemp-derived CBD market with a letter of intent to acquire Vivis, an emerging retail brand of hemp-based health and nutritional products. Vivis’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
- J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.
- Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
- ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.
Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.
Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.
Neutra Corp. (OTCQB: NTRR), closed Thursday's trading session at $0.0009, off by 10.00%, on 18,005,662 volume with 51 trades. The average volume for the last 3 months is 23,879,541 and the stock's 52-week low/high is $0.000799999/$0.097350001.
- Neutra Corp. (NTRR) Building Vertically to Establish Nutraceutical Revenues Through Hemp-Based CBD
- Neutra Corp. (NTRR) Targets Hemp-Based CBD Market
- Neutra Corp. (NTRR) CEO Discusses CBD as Chronic Pain Treatment
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Coverage Initiated for B2Digital Inc. via NetworkNewsWire
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) CEO Rings Nasdaq Opening Bell
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Announces Appointment of New Directors, Chairman to Corporate Board
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Opens the TSX Market
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Provides Washington State Update from Sugarleaf
- ChineseInvestors.com (CIIX) Announces 175% Sales Increase, Launch of Six New Hemp-Infused Skincare Products
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Achieves Listing, Commences Trading on OTCQB Venture Market
- CloudCommerce (OTCQB: CLWD) Market-Behavior Tool Utilizes AI to Bolster Communication Campaigns
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Earth Science Tech, Inc. (ETST) Expands in the CBD Space, Establishes New Sales Unit
- Endonovo Therapeutics (OTCQB: ENDV) Receives Glowing Video Review on Revolutionary Medical Device
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers
- Geyser Brands Inc. (TSX.V: GYSR) Subsidiary Receives Natural Health Product Number from Health Canada
- Grapefruit Boulevard Investments Inc. (IGNG) 420 with CNW – Governor Cuomo Hints Cannabis Smoking Ban Could Be Included in Next Legalization Bill
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) to Report Results, Host Earnings Conference Call for Q4 and Fiscal Year 2019
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – The Benefits of Marijuana During Breast Cancer Treatment
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) 420 with CNW – Marijuana Banking Bill Changes Suggested to Win Republican Support
- INmune Bio, Inc. (NASDAQ: INMB) CEO Discusses Company Achievements in Interview; Director of Neuroscience to Present at World Immunotherapy Congress
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Secures DTC Eligibility for U.S. Markets
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Powdered Formulation of CBD-Rich Hemp Oil Now Available to US Consumers
- Marijuana Company of America Inc. (MCOAD) 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
- MustGrow Biologics Corp (CSE: MGRO) 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
- Neutra Corp. (OTCQB: NTRR) CEO Discusses CBD as Chronic Pain Treatment
- Nightfood, Inc. (OTCQB: NGTF) Delivers Update on Recent Activities and Developments
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) One of the Largest Licensed Cannabis Producers in Canada
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Ongoing Drill Results Confirm Significant, Near Surface Cobalt and Nickel Mineralization
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Recommencement of Production at Asphalt Ridge Facility
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Launches New Line of Best Selling Gummies in California
- Predictive Oncology Inc. (NASDAQ: POAI) Transforming Cancer-Treatment Outcomes via Proprietary Database
- Pressure BioSciences Inc. (PBIO) Proprietary Technology Platform Identified as Key Cancer Biomarker Research Element
- Quest Patent Research Corp. (QPRC) Holds Broad Portfolio of Intellectual Property Assets
- Sharing Services Global Corporation (SHRG) Growing Global Network, Adds Thousands of Independent Representatives
- SinglePoint, Inc. (SING) Deploys Successful Pure Hemp Cigarette Marketing Strategy Ahead of NACS Event
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives $800,000 Purchase Order for its UR7 Rugged Clamshell Handset
- Spectrum Global Solutions, Inc. (SGSI) Prepared to Support 5G Technology
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces Expansion With New Manufacturing Facility
- SRAX Inc. (NASDAQ: SRAX) to Present at the 5th Annual B. Riley Consumer and Media Conference in NYC
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate at September 17 Battery Next Summit in Boulder, CO
- Sugarmade, Inc. (SGMD) 420 with CNW – Medical Marijuana Prices in Michigan Rise as Recreational Sales Near
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expanding Globally through Strategic Partnerships
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Confirms Robust Demand for Premium Organic Cannabis
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) 420 with CNW – Mexican Senate to Start Debating Cannabis Legalization This Week
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Completes SolDaze Acquisition
- Trxade Group Inc. (TRXD) Tech Solutions Like Those from Trxade Group Can Help Independent Pharmacies Thrive in the Future
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Announces Partnership with Linneo Health to Supply Medical Cannabis in Europe
- VPR Brands, LP (VPRB) Gearing Up to Launch Vape Battery Line
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Developing Robust Retail Network for CBD Products
- Willow Biosciences Inc. (CSE: WLLW) 420 with CNW – Massachusetts Lawmakers Move to Address Vaping Dangers
- Xalles Holdings Inc. (XALL) Achieves Five Consecutive Revenue-Producing Quarters
- Youngevity International, Inc. (NASDAQ: YGYI) Announces Closing of Public Offering of Series D Cumulative Redeemable Perpetual Preferred Stock Offering
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.